DMARDs-话题@MedSci

#DMARDs#

13篇内容 | 1452人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2209268, encodeId=2eaf22092687c, content=<a href='/topic/show?id=019a60434f' target=_blank style='color:#2F92EE;'>#DMARDs#</a> <a href='/topic/show?id=75b01153e76e' target=_blank style='color:#2F92EE;'>#难治性类风湿关节炎#</a> <a href='/topic/show?id=9f691144660c' target=_blank style='color:#2F92EE;'>#EULAR 2024#</a>, objectTitle=EULAR 2024 ：生物制剂或靶向合成DMARDs在难治性类风湿关节炎患者中的治疗潜力, objectType=article, longId=829619, objectId=e062829619ca, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240606/1717679081671_8624274.png, objectUrl=/article/show_article.do?id=e062829619ca, replyNumber=0, likeNumber=93, createdTime=2024-06-10, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=e062829619ca, moduleTitle=EULAR 2024 ：生物制剂或靶向合成DMARDs在难治性类风湿关节炎患者中的治疗潜力, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e062829619ca)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1395323, encodeId=ff8d1395323a0, content=<a href='/topic/show?id=019a60434f' target=_blank style='color:#2F92EE;'>#DMARDs#</a>, objectTitle=生物制剂DMARDs治疗方案的常见临床问题, objectType=article, longId=738089, objectId=f912e3808982, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f912e3808982, replyNumber=0, likeNumber=101, createdTime=2022-09-07, rootId=0, userName=12498dd9m11暂无昵称, userId=b3ad2500191, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f912e3808982, moduleTitle=生物制剂DMARDs治疗方案的常见临床问题, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f912e3808982)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1395322, encodeId=ad5a139532244, content=<a href='/topic/show?id=019a60434f' target=_blank style='color:#2F92EE;'>#DMARDs#</a>, objectTitle=Rheumatology：巴瑞替尼、托法替布与bDMARDS治疗类风湿关节炎的疗效比较, objectType=article, longId=299909, objectId=e2b12999097b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e2b12999097b, replyNumber=0, likeNumber=124, createdTime=2022-03-03, rootId=0, userName=12498dd9m11暂无昵称, userId=b3ad2500191, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e2b12999097b, moduleTitle=Rheumatology：巴瑞替尼、托法替布与bDMARDS治疗类风湿关节炎的疗效比较, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e2b12999097b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1395321, encodeId=07661395321f8, content=<a href='/topic/show?id=019a60434f' target=_blank style='color:#2F92EE;'>#DMARDs#</a>, objectTitle=Rheumatology：巴利西替尼和托法替尼与bDMARDS治疗类风湿关节炎的疗效比较, objectType=article, longId=299676, objectId=75a62996e6e1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=75a62996e6e1, replyNumber=0, likeNumber=71, createdTime=2022-02-27, rootId=0, userName=12498dd9m11暂无昵称, userId=b3ad2500191, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=75a62996e6e1, moduleTitle=Rheumatology：巴利西替尼和托法替尼与bDMARDS治疗类风湿关节炎的疗效比较, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=75a62996e6e1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1395320, encodeId=2b591395320a9, content=<a href='/topic/show?id=019a60434f' target=_blank style='color:#2F92EE;'>#DMARDs#</a>, objectTitle=Semin Arthritis Rheu：tDMARDs治疗的风湿病患者COVID-19的发病率, objectType=article, longId=194466, objectId=820119446689, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=820119446689, replyNumber=0, likeNumber=90, createdTime=2020-05-22, rootId=0, userName=12498dd9m11暂无昵称, userId=b3ad2500191, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=820119446689, moduleTitle=Semin Arthritis Rheu：tDMARDs治疗的风湿病患者COVID-19的发病率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=820119446689)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1395319, encodeId=a15b1395319d6, content=<a href='/topic/show?id=019a60434f' target=_blank style='color:#2F92EE;'>#DMARDs#</a>, objectTitle=2020 香港共识声明：生物类改善病情的抗风湿药(DMARDs)治疗多关节型JIA、附着点炎相关关节炎和银屑病关节炎, objectType=article, longId=189059, objectId=393618905962, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=393618905962, replyNumber=0, likeNumber=83, createdTime=2020-03-02, rootId=0, userName=12498dd9m11暂无昵称, userId=b3ad2500191, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=393618905962, moduleTitle=2020 香港共识声明：生物类改善病情的抗风湿药(DMARDs)治疗多关节型JIA、附着点炎相关关节炎和银屑病关节炎, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=393618905962)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1395318, encodeId=625913953180b, content=<a href='/topic/show?id=019a60434f' target=_blank style='color:#2F92EE;'>#DMARDs#</a>, objectTitle=Ann Rheum Dis：类风湿性关节炎病程和既往使用DMARDs对治疗结局的影响, objectType=article, longId=178120, objectId=f7071e8120be, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f7071e8120be, replyNumber=0, likeNumber=67, createdTime=2019-08-24, rootId=0, userName=12498dd9m11暂无昵称, userId=b3ad2500191, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f7071e8120be, moduleTitle=Ann Rheum Dis：类风湿性关节炎病程和既往使用DMARDs对治疗结局的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f7071e8120be)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1395317, encodeId=eed7139531eee, content=<a href='/topic/show?id=019a60434f' target=_blank style='color:#2F92EE;'>#DMARDs#</a>, objectTitle=Ann Rheum Dis：类风湿性关节炎患者疾病控制后逐渐减少TNF抑制剂与常规合成DMARDs的比较, objectType=article, longId=163822, objectId=8ea416382257, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8ea416382257, replyNumber=0, likeNumber=88, createdTime=2019-04-10, rootId=0, userName=12498dd9m11暂无昵称, userId=b3ad2500191, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8ea416382257, moduleTitle=Ann Rheum Dis：类风湿性关节炎患者疾病控制后逐渐减少TNF抑制剂与常规合成DMARDs的比较, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8ea416382257)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1395316, encodeId=2750139531657, content=<a href='/topic/show?id=019a60434f' target=_blank style='color:#2F92EE;'>#DMARDs#</a>, objectTitle=Semin Arthritis Rheu：两种bDMARDs联合治疗类风湿性关节炎的安全性, objectType=article, longId=156410, objectId=2f321564100d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2f321564100d, replyNumber=0, likeNumber=0, createdTime=2018-12-24, rootId=0, userName=12498dd9m11暂无昵称, userId=b3ad2500191, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2f321564100d, moduleTitle=Semin Arthritis Rheu：两种bDMARDs联合治疗类风湿性关节炎的安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2f321564100d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1395315, encodeId=c1e51395315e3, content=<a href='/topic/show?id=019a60434f' target=_blank style='color:#2F92EE;'>#DMARDs#</a>, objectTitle=Ann Rheum Dis：RA患者：bDMARDs引入后髋和膝关节置换术发生率有改变吗？, objectType=article, longId=139106, objectId=1be8139106c6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1be8139106c6, replyNumber=0, likeNumber=82, createdTime=2018-05-27, rootId=0, userName=12498dd9m11暂无昵称, userId=b3ad2500191, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1be8139106c6, moduleTitle=Ann Rheum Dis：RA患者：bDMARDs引入后髋和膝关节置换术发生率有改变吗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1be8139106c6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1395314, encodeId=037313953145e, content=<a href='/topic/show?id=019a60434f' target=_blank style='color:#2F92EE;'>#DMARDs#</a>, objectTitle=Ann Rheum Dis：托珠单抗与TNFi单药或与常规DMARDs联合治疗类风湿性关节炎的疗效比较, objectType=article, longId=137675, objectId=d4a413e67570, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d4a413e67570, replyNumber=0, likeNumber=69, createdTime=2018-05-11, rootId=0, userName=12498dd9m11暂无昵称, userId=b3ad2500191, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d4a413e67570, moduleTitle=Ann Rheum Dis：托珠单抗与TNFi单药或与常规DMARDs联合治疗类风湿性关节炎的疗效比较, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d4a413e67570)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1395313, encodeId=dbfb139531352, content=<a href='/topic/show?id=019a60434f' target=_blank style='color:#2F92EE;'>#DMARDs#</a>, objectTitle=Ann Rheum Dis：引入生物性DMARDs后类风湿性关节炎髋关节和膝关节置换的发生率, objectType=article, longId=124095, objectId=57271240955d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=57271240955d, replyNumber=0, likeNumber=74, createdTime=2017-12-22, rootId=0, userName=12498dd9m11暂无昵称, userId=b3ad2500191, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=57271240955d, moduleTitle=Ann Rheum Dis：引入生物性DMARDs后类风湿性关节炎髋关节和膝关节置换的发生率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=57271240955d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1395312, encodeId=2c311395312ae, content=<a href='/topic/show?id=019a60434f' target=_blank style='color:#2F92EE;'>#DMARDs#</a>, objectTitle=Ann Rheum Dis：使用生物性DMARDs治疗的类风湿性关节炎患者继发性恶性肿瘤和死亡的风险, objectType=article, longId=122969, objectId=df0a122969f5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=df0a122969f5, replyNumber=0, likeNumber=83, createdTime=2017-12-12, rootId=0, userName=12498dd9m11暂无昵称, userId=b3ad2500191, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=df0a122969f5, moduleTitle=Ann Rheum Dis：使用生物性DMARDs治疗的类风湿性关节炎患者继发性恶性肿瘤和死亡的风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=df0a122969f5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1395311, encodeId=229313953115e, content=<a href='/topic/show?id=019a60434f' target=_blank style='color:#2F92EE;'>#DMARDs#</a>, objectTitle=Ann Rheum Dis：bDMARDs治疗RA患者的严重感染, objectType=article, longId=75937, objectId=d30de593766, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d30de593766, replyNumber=0, likeNumber=101, createdTime=2016-08-27, rootId=0, userName=12498dd9m11暂无昵称, userId=b3ad2500191, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d30de593766, moduleTitle=Ann Rheum Dis：bDMARDs治疗RA患者的严重感染, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d30de593766)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

DMARDs

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#DMARDs# #难治性类风湿关节炎# #EULAR 2024#

EULAR 2024 ：生物制剂或靶向合成DMARDs在难治性类风湿关节炎患者中的治疗潜力

2024-06-10发表于上海

12498dd9m11暂无昵称 (审核中...)

前往app查看评论内容

#DMARDs#

生物制剂DMARDs治疗方案的常见临床问题

2022-09-07

12498dd9m11暂无昵称 (审核中...)

前往app查看评论内容

#DMARDs#

Rheumatology：巴瑞替尼、托法替布与bDMARDS治疗类风湿关节炎的疗效比较

2022-03-03

12498dd9m11暂无昵称 (审核中...)

前往app查看评论内容

#DMARDs#

Rheumatology：巴利西替尼和托法替尼与bDMARDS治疗类风湿关节炎的疗效比较

2022-02-27

12498dd9m11暂无昵称 (审核中...)

前往app查看评论内容

#DMARDs#

Semin Arthritis Rheu：tDMARDs治疗的风湿病患者COVID-19的发病率

2020-05-22

12498dd9m11暂无昵称 (审核中...)

前往app查看评论内容

#DMARDs#

2020 香港共识声明：生物类改善病情的抗风湿药(DMARDs)治疗多关节型JIA、附着点炎相关关节炎和银屑病关节炎

2020-03-02

12498dd9m11暂无昵称 (审核中...)

前往app查看评论内容

#DMARDs#

Ann Rheum Dis：类风湿性关节炎病程和既往使用DMARDs对治疗结局的影响

2019-08-24

12498dd9m11暂无昵称 (审核中...)

前往app查看评论内容

#DMARDs#

Ann Rheum Dis：类风湿性关节炎患者疾病控制后逐渐减少TNF抑制剂与常规合成DMARDs的比较

2019-04-10

12498dd9m11暂无昵称 (审核中...)

前往app查看评论内容

#DMARDs#

Semin Arthritis Rheu：两种bDMARDs联合治疗类风湿性关节炎的安全性

2018-12-24

12498dd9m11暂无昵称 (审核中...)

前往app查看评论内容

#DMARDs#

Ann Rheum Dis：RA患者：bDMARDs引入后髋和膝关节置换术发生率有改变吗？

2018-05-27

12498dd9m11暂无昵称 (审核中...)

前往app查看评论内容

#DMARDs#

Ann Rheum Dis：托珠单抗与TNFi单药或与常规DMARDs联合治疗类风湿性关节炎的疗效比较

2018-05-11

12498dd9m11暂无昵称 (审核中...)

前往app查看评论内容

#DMARDs#

Ann Rheum Dis：引入生物性DMARDs后类风湿性关节炎髋关节和膝关节置换的发生率

2017-12-22

12498dd9m11暂无昵称 (审核中...)

前往app查看评论内容

#DMARDs#

Ann Rheum Dis：使用生物性DMARDs治疗的类风湿性关节炎患者继发性恶性肿瘤和死亡的风险

2017-12-12

12498dd9m11暂无昵称 (审核中...)

前往app查看评论内容

#DMARDs#

Ann Rheum Dis：bDMARDs治疗RA患者的严重感染

2016-08-27

科室
- - 订阅+
  - 更多科室
工具
服务